Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Oncogenic activity of SOX1 in glioblastoma.

Garcia I, Aldaregia J, Marjanovic Vicentic J, Aldaz P, Moreno-Cugnon L, Torres-Bayona S, Carrasco-Garcia E, Garros-Regulez L, Egaña L, Rubio A, Pollard S, Stevanovic M, Sampron N, Matheu A.

Sci Rep. 2017 Apr 20;7:46575. doi: 10.1038/srep46575.

2.

Erratum to: Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).

Rivero-Calle I, Pardo-Seco J, Aldaz P, Vargas DA, Mascarós E, Redondo E, Díaz-Maroto JL, Linares-Rufo M, Fierro-Alacio MJ, Gil A, Molina J, Ocaña D, Martinón-Torres F; NEUMOEXPERTOS group.

BMC Infect Dis. 2017 Jan 12;17(1):64. doi: 10.1186/s12879-016-2134-6. No abstract available.

3.

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma.

Garros-Regulez L, Garcia I, Carrasco-Garcia E, Lantero A, Aldaz P, Moreno-Cugnon L, Arrizabalaga O, Undabeitia J, Torres-Bayona S, Villanua J, Ruiz I, Egaña L, Sampron N, Matheu A.

Front Oncol. 2016 Oct 24;6:222. eCollection 2016. Review.

4.

Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).

Rivero-Calle I, Pardo-Seco J, Aldaz P, Vargas DA, Mascarós E, Redondo E, Díaz-Maroto JL, Linares-Rufo M, Fierro-Alacio MJ, Gil A, Molina J, Ocaña D, Martinón-Torres F; NEUMOEXPERTOS group.

BMC Infect Dis. 2016 Nov 7;16(1):645. Erratum in: BMC Infect Dis. 2017 Jan 12;17 (1):64.

5.

SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression.

Santos JC, Carrasco-Garcia E, Garcia-Puga M, Aldaz P, Montes M, Fernandez-Reyes M, de Oliveira CC, Lawrie CH, Araúzo-Bravo MJ, Ribeiro ML, Matheu A.

Cancer Res. 2016 Nov 15;76(22):6735-6746. doi: 10.1158/0008-5472.CAN-16-1120. Epub 2016 Aug 28.

6.

SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin.

Carrasco-Garcia E, Lopez L, Aldaz P, Arevalo S, Aldaregia J, Egaña L, Bujanda L, Cheung M, Sampron N, Garcia I, Matheu A.

Sci Rep. 2016 Aug 30;6:32350. doi: 10.1038/srep32350.

7.

Stratification and therapeutic potential of PML in metastatic breast cancer.

Martín-Martín N, Piva M, Urosevic J, Aldaz P, Sutherland JD, Fernández-Ruiz S, Arreal L, Torrano V, Cortazar AR, Planet E, Guiu M, Radosevic-Robin N, Garcia S, Macías I, Salvador F, Domenici G, Rueda OM, Zabala-Letona A, Arruabarrena-Aristorena A, Zúñiga-García P, Caro-Maldonado A, Valcárcel-Jiménez L, Sánchez-Mosquera P, Varela-Rey M, Martínez-Chantar ML, Anguita J, Ibrahim YH, Scaltriti M, Lawrie CH, Aransay AM, Iovanna JL, Baselga J, Caldas C, Barrio R, Serra V, Vivanco Md, Matheu A, Gomis RR, Carracedo A.

Nat Commun. 2016 Aug 24;7:12595. doi: 10.1038/ncomms12595.

8.

Indirect costs associated with glioblastoma: Experience at one hospital.

Undabeitia J, Torres-Bayona S, Samprón N, Arrázola M, Bollar A, Armendariz M, Torres P, Ruiz I, Caballero MC, Egaña L, Querejeta A, Villanua J, Pardo E, Etxegoien I, Liceaga G, Urtasun M, Michan M, Emparanza JI, Aldaz P, Matheu A, Úrculo E.

Neurologia. 2016 Jul 20. pii: S0213-4853(16)30079-2. doi: 10.1016/j.nrl.2016.05.003. [Epub ahead of print] English, Spanish.

9.

mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.

Garros-Regulez L, Aldaz P, Arrizabalaga O, Moncho-Amor V, Carrasco-Garcia E, Manterola L, Moreno-Cugnon L, Barrena C, Villanua J, Ruiz I, Pollard S, Lovell-Badge R, Sampron N, Garcia I, Matheu A.

Expert Opin Ther Targets. 2016;20(4):393-405. doi: 10.1517/14728222.2016.1151002.

10.

[Harmonisation of databases for the study of frailty in older people: INTAFRADE study].

Machón M, Egüés N, Martínez N, Abellán van Kan G, Calderón-Larrañaga A, Aldaz P, Poblador-Plou B, Vrotsou K, Clerencia-Sierra M, Prados-Torres A, Vergara I.

Rev Esp Geriatr Gerontol. 2016 Jan-Feb;51(1):29-36. doi: 10.1016/j.regg.2015.10.002. Epub 2015 Nov 21. Spanish.

PMID:
26613655
11.

Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.

Martínez-Baz I, Navascués A, Pozo F, Chamorro J, Albeniz E, Casado I, Reina G, Cenoz MG, Ezpeleta C, Castilla J; Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra.

Hum Vaccin Immunother. 2015;11(7):1626-33. doi: 10.1080/21645515.2015.1038002.

12.

Household transmission of influenza A(H1N1)pdm09 in the pandemic and post-pandemic seasons.

Casado I, Martínez-Baz I, Burgui R, Irisarri F, Arriazu M, Elía F, Navascués A, Ezpeleta C, Aldaz P, Castilla J; Primary Health Care Sentinel Network of Navarra.

PLoS One. 2014 Sep 25;9(9):e108485. doi: 10.1371/journal.pone.0108485. eCollection 2014.

13.

[Effect of Royal Decree-Law 16/2012 on consumption of drugs excluded from public coverage in Navarre (Spain)].

Aldaz P, Escalada D, Martínez-Monreal B, Azparren A, Ursúa ME.

Gac Sanit. 2015 Jan-Feb;29(1):77-8. doi: 10.1016/j.gaceta.2014.07.012. Epub 2014 Sep 8. Spanish. No abstract available.

14.

Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.

Castilla J, Martínez-Baz I, Navascués A, Fernandez-Alonso M, Reina G, Guevara M, Chamorro J, Ortega MT, Albéniz E, Pozo F, Ezpeleta C; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre.

Euro Surveill. 2014 Feb 13;19(6). pii: 20700.

15.

[Herpes zoster incidence in diabetic patients].

Aldaz P, Díaz JA, Loayssa JR, Dronda MJ, Oscáriz M, Castilla J.

An Sist Sanit Navar. 2013 Jan-Apr;36(1):57-62. Spanish.

16.

Therapeutic strategies targeting glioblastoma stem cells.

Carrasco-Garcia E, Sampron N, Aldaz P, Arrizabalaga O, Villanua J, Barrena C, Ruiz I, Arrazola M, Lawrie C, Matheu A.

Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):216-27. Review.

PMID:
23607282
17.

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study.

Martínez-Baz I, Martínez-Artola V, Reina G, Guevara M, Cenoz MG, Morán J, Irisarri F, Arriazu M, Albeniz E, Castilla J; Primary Health Care Sentinel Network of Navarre.

BMC Public Health. 2013 Mar 6;13:191. doi: 10.1186/1471-2458-13-191.

18.

Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.

Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, Albéniz E, Ezpeleta C, Barricarte A; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre.

Euro Surveill. 2013 Jan 31;18(5). pii: 20388.

19.

[Consensus document on vaccination against influenza in health care workers].

Picazo JJ, Alonso LM, Arístegui J, Bayas JM, Sanz J, Del Amo P, Cobos JL, Rodríguez-Salazar J, Sánchez-Pastor M, de la Cámara R, Carratalá J, Cañada JL, González-Del Castillo J, Aldaz P, Pérez-Escanilla F, Barberán J, Rodríguez A, Vigil-Escribano D, Espinosa-Arranz J, Blanquer J, González-Romo F.

Rev Esp Quimioter. 2012 Sep;25(3):226-39. Spanish.

20.

Factors associated with continued adherence to influenza vaccination in the elderly.

Martínez-Baz I, Aguilar I, Morán J, Albéniz E, Aldaz P, Castilla J.

Prev Med. 2012 Sep;55(3):246-50. doi: 10.1016/j.ypmed.2012.06.020. Epub 2012 Jun 30.

PMID:
22759626

Supplemental Content

Loading ...
Support Center